KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Accounts Payables (2017 - 2025)

Elanco Animal Health's Accounts Payables history spans 9 years, with the latest figure at $368.0 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 24.32% year-over-year to $368.0 million; the TTM value through Dec 2025 reached $368.0 million, up 24.32%, while the annual FY2025 figure was $368.0 million, 24.32% up from the prior year.
  • Accounts Payables for Q4 2025 was $368.0 million at Elanco Animal Health, up from $352.0 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $506.0 million in Q2 2021 and bottomed at $259.0 million in Q3 2024.
  • The 5-year median for Accounts Payables is $361.0 million (2023), against an average of $358.2 million.
  • The largest annual shift saw Accounts Payables skyrocketed 108.66% in 2021 before it tumbled 30.77% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $416.0 million in 2021, then fell by 6.25% to $390.0 million in 2022, then crashed by 30.77% to $270.0 million in 2023, then increased by 9.63% to $296.0 million in 2024, then grew by 24.32% to $368.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Accounts Payables are $368.0 million (Q4 2025), $352.0 million (Q3 2025), and $368.0 million (Q2 2025).